Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2026 Jan 1:2025.12.30.697051. [Version 2] doi: 10.64898/2025.12.30.697051

Multi-modal choroid plexus pathology in aging and Alzheimer’s disease

Huixin Xu, Peter Lotfy, Benjamin Englert, Jane Oberhauser, Lillian IJ Byer, Jasmin Wihlman, Kia Colangelo, Serhat V Okar, Ashley Thommana, Henri Puttonen, Mikko I Mäyränpää, Jarno Tuimala, Rute Pedrosa, Darshan Kumar, James Francis Haberberger, Micaiah Emmy Atkins, Shon Alimukhamedov, Aja Pragana, Jordan Benson, Mary Elizabeth Gabrielle, Anna Dong, Violeta Durán Laforet, Peter Bor-Chian Lin, C Dirk Keene, Caitlin S Latimer, Katherine E Prater, David M Holtzman, Alina Isakova, Tony Wyss-Coray, Dorothy P Schafer, Daniel S Reich, Terho Lehtimäki, Pekka J Karhunen, Eloise H Kok, Deidre Jansson, Andrew C Yang, Liisa Myllykangas, Jose Ordovas-Montanes, Maria K Lehtinen
PMCID: PMC12776263  PMID: 41509283

ABSTRACT

Brain barriers, cerebrospinal fluid (CSF) dynamics, and peripheral factors are implicated as significant contributors to Alzheimer’s disease (AD). The choroid plexus (ChP) is a blood-brain interface that produces CSF and forms the blood-CSF barrier. However, how ChP pathology develops across the lifespan and contributes to AD has not been systematically characterized. Here, we report a multi-modal ChP atlas integrating single-nucleus transcriptomics from 49 individuals, AI-assisted quantitative histopathology across >500 postmortem samples age 16 to 105, spatial transcriptomics, and functional studies in 5xFAD mice. We identify fibrosis, calcification, and macrophage abnormalities as hallmarks of ChP aging, with AD pathology conferring additional effects, including expansion of a pro-inflammatory fibroblast-macrophage signaling niche. In 5xFAD mice, macrophage dysfunction is associated with impaired epithelial barrier maintenance and repair. Together, these data provide a foundational resource for understanding ChP dysfunction in aging and AD and propose the macrophage-fibroblast-epithelial barrier axis as a driver of ChP pathology.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES